| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005219A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/03/2000 | WO2000005218A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 02/03/2000 | WO2000005217A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004917A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 02/03/2000 | WO2000004865A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999058504A9 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/03/2000 | WO1999058145A3 Immunomodulators for vaccines |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2714833A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338310A1 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 02/03/2000 | CA2338305A1 Imidazole compounds |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2338044A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 02/03/2000 | CA2337954A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335655A1 Keratinocyte derived interferon |
| 02/03/2000 | CA2335653A1 Molecules associated with cell proliferation |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2334947A1 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | CA2334047A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/02/2000 | EP0976403A1 Adjuvant comprising pulmonary surfactant |
| 02/02/2000 | EP0975661A1 The proliferation of cell-inhibiting peptide and its use |
| 02/02/2000 | EP0975636A1 Novel compounds |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975597A1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 02/02/2000 | EP0975592A1 Benzyloxy prodigiosine compounds |
| 02/02/2000 | EP0975364A1 Allergen formulation |
| 02/02/2000 | EP0975362A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975359A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase |
| 02/02/2000 | EP0975351A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 02/02/2000 | EP0975225A1 Fibrocyte-based cellular therapy formulations |
| 02/02/2000 | EP0900078B1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system |
| 02/02/2000 | EP0863915B1 Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 02/02/2000 | EP0820284B1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 02/02/2000 | EP0674516B1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/01/2000 | US6020510 Cytoprotective compounds |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020381 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of protozoan infections |
| 02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |
| 02/01/2000 | US6020351 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/01/2000 | US6020346 Piperidine derivatives having tachykinin antagonist activity |
| 02/01/2000 | US6020315 Preparation having increased in vivo tolerability |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020172 Nucleic acid delivery with ovine adenoviral vectors |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6019985 Immunostimulation methods for providing disease protection in poultry |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | US6019979 Anti-viral treatment with pertussis toxin B oligomer |
| 02/01/2000 | US6019978 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
| 02/01/2000 | US6019971 Treatment of autoimmune arthritis by oral administration of collagen |
| 02/01/2000 | US6019968 Dispersible antibody compositions and methods for their preparation and use |
| 01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004033A1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000004016A2 Polymorph of ritonavir |
| 01/27/2000 | WO2000003977A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | WO2000003744A2 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 01/27/2000 | WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO2000003702A1 New pharmaceutical preparation and method |
| 01/27/2000 | WO1999059624A3 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 01/27/2000 | CA2674800A1 Polymorph of a pharmaceutical |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2337850A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | CA2337049A1 New pharmaceutical preparation and method |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974589A1 Benzimidazole derivatives and pharmaceutically acceptable salts thereof |